Formulation and evaluation of Antiurolithiatic herbal tablet by Gupta, Dishant & Dubey, P.K.
Gupta et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):908-913  
ISSN: 2250-1177                                                                                  [908]                                                                                 CODEN (USA): JDDTAO 
Available online on 25.08.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Formulation and evaluation of Antiurolithiatic herbal tablet 
Dishant Gupta*, Dr. P.K. Dubey# 
*Ph.D. Research Scholar JJT University Jhunjhunu (Raj.), India 
# Principal, Swami Vivekanand college of Pharmacy, Indore, India 
 
ABSTRACT 
Phytomedicine based on principles of Ayurveda are need of the hour and is more feasible than allopathic drugs which is not only more 
expensive in terms of “leads” but is also associated with many unwanted effects. Ethnopharmacological usage and the literature review 
revealed that the Abutilon indicum, Zea mays, Tribulus terrestris, Phyllanthus niruri  have significant antiurolithiatic activity. After the detailed 
study of powder of ethanolic extract of seeds of abutilon indicum, tassel of zea mays,fruits of Tribulus terrestris and leaves of Phyllanthus niruri a 
formulation using the plant materials was prepared. The formulation was evaluated and standardized as per the Pharmacopoeial standards. 
The results of preformulation studies revealed that all the values were within acceptable limit. Formulation showed appreciable hardness 
characteristics (4.35 kg/cm2), which facilitates its fast disintegration. The friability (0.8%) of formulation indicated that the tablets were 
mechanically stable. As the average weight of tablets was 505 mg, the acceptable weight variation range is ±7%. Hence the entire formulated 
tablet passed the weight variation test. The disintegration time of formulations was more than 1 minute. Thus the claims made  by the 
traditional Indian systems of medicine regarding the use of this plant in the treatment of antiurolithiatic activity confirmed. The final conclusion 
drawn from the above mentioned data is that the possible use of these economical and relatively nontoxic, non-hazardous natural remedies of 
plant origin may further be explored as they are devoid of major side effects associated with synthetic agents.  
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Urinary stone disease continues to reside in an important 
place in daily urological practice. The average life time risk 
of stone formation has been reported in the range of 5-10 %. 
A predominance of men over women can be observed with 
an incidence peak between the fourth and fifth decade of life. 
(Yadav R. D., 2011). Abutilon indicum species has been 
widely used as medicine in Ayurvedic system of medicine. 
Abutilon indicum (Malvaceae), commonly known as “Thuthi” 
is distributed throughout the hotter parts of India. Abutilon 
indicum commonly known as “Atibala” in Sanskrit gives 
excessive tonic strength. Phytoconstituents like β‐Sitosterol 
(0.2%), tocopherol oil (0.3%) were isolated. ( Dashputre N. 
L.,2010) 
The word zea mays come from two languages. Zea comes 
from ancient greek and is a generic name for cereal and 
grains. In traditional medicine, corn is used for relieving 
diarrhea, dysentery, urinary tract disorder, prostatitis, 
lithiasis, angina, hypertension and tumor. ( Parle M., 2013) 
Tribulus terrestris    is commonly known as puncture vine, 
caltrop, yellow vine, goat head and devil’s horn. It is is a 
member of the Zygophyllaceae family and is widely 
distributed in both tropical and mild temperate regions. T. 
terrestris is native to warm temperate and tropical regions of 
southern Europe, southern and western Asia, throughout 
Africa, and Australia. Phyllanthus niruri is an important 
medicinal plant. The plant is widely used for the treatment 
of hepatic disease, oedema, dropsical condition, and urinary 
troubles. 
2. MATERIALS AND METHODS 
2.1 Description of plant  
Abutilon indicum:- The botanical name of atibala is Abutilon 
indicum and it belongs to family Malvaceae.The plant grows 
throughout India and in Sri Lanka, at about an elevation of 
1000-1, 500 meters. The perennial shrub grows 1.25-2 
meters in height. Plant covered with minute hairs. Leaves 
are alternate, cordate and acute. The leaves are oblong, 
opposite, toothed, smooth and covered with fine white hair. 
The flowers are yellow, 2.5 cm in diameter.  
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Zea mays:- The word zea mays comes from two languages. 
Zea comes from ancient greek and is a generic name for 
cereal and grains. In traditional medicine, corn is used for 
relieving diarrhea, dysentery, urinary tract disorder, 
prostatitis, lithiasis, angina, hypertension and tumor.  
Tribulus terrestris    is commonly known as puncture vine, 
caltrop, yellow vine, goat head and devil’s horn. It is is a 
member of the Zygophyllaceae family and is widely 
distributed in both tropical and mild temperate regions T. 
terrestris is native to warm temperate and tropical regions of 
southern Europe, southern and western Asia, throughout 
Africa, and Australia.  
Phyllanthus niruri originated in India, usually occurring as 
a winter weed throughout the hotter parts. The Phyllanthus 
genus contains over 600 species of shrubs, trees and annual 
or biennial herbs distributed throughout the tropical and 
subtropical areas. Phyllanthus niruri is a herb of 
Euphorbiaceae family that grows upto 60 cm. Phyllanthus 
niruri is an annual herb which grows in the wild after first 
showers of monsoon in Jharkhand, Bihar, Chhattisgarh, etc. 
states of India. Extracts of this herb have been proven to 
have therapeutic effects in many clinical studies. Phyllanthus 
niruri is an important medicinal plant. The plant is widely 
used for the treatment of hepatic disease, oedema, dropsical 
condition, and urinary troubles. 
Extraction 
The dried parts of crude drugs were powdered, weighed 
(500g) and filled in soxhlet apparatus for solvent extraction.  
The powdered drug was defatted with petroleum ether. (60-
80o C).Defatted drug was then dried and again filled in 
soxhlet apparatus for solvent extraction with solvent 
ethanol. Solvents were evaporated to get the dried residue of 
extract. Percentage yield were calculated for each extract. 
(Kokate, C. K. 2000) 
2. 2. Formulation 
2.2.1 Powdering of extracts: - Colloidal silicon dioxide 
(Aerosil 200) was added to the extract in a percentage of 2% 
of adjuvant to dry residue. 
2.2.2 Preformulation Studies  
The following Preformulation studies were performed: 
 Organoleptic studies  
 Solubility testing  
 Angle of repose 
 Loss on drying: 
 Total Ash value determination 
 Bulk density 
 Tapped density  
 % Compressibility 
 Hausner ratio 
 pH 
 Particle size  
 Extract Excipient Compatibility studies 
2.2.2.1 Organoleptic studies: In these studies the 
organollepic features like colour, odour and physical 
appearance were observed and recorded. 
2.2.2.2 Solubility testing 
The solubility’s were checked in water pH (7.0), 0.1 N 
hydrochloric acid solution, absolute alcohol, ethyl acetate, 
and hexane. 
2.2.2.3 Angle of repose 
Angle of repose is an important parameter to study the Flow 
property analysis of any powdered formulation with respect 
to their frictional forces. Angle of repose is defined as the 
maximum angel between the surface of the pile of powdered 
sample and the horizontal plane. Mathematically angle of 
repose is calculated by height of the pile (H) divided by 
radius of the pile(R). (Lachman, L.et al. 1991,Aulton, et al. 
1999,  Martin et al. 2005) 
Angle of repose (Tan θ) = height of the pile (H)/ radius of the 
pile(R) 
Table 1 Relationship between Angle of repose and 
powder Flow property 
s.no. Angle of repose Flow property 
1. <25 Excellent 
2. 20-30 Good 
3. 30-40 Passable 
4. >40 Very poor 
 
2.2.2.4 Loss on drying 
Weighing bottle was dried a in a oven at 105ºC.and weight 
(w1) was taken. 3 g of the drug was placed in it. The drug 
was dried in oven at 100-105 º C for 3 hrs. Drug was then 
allowed to cool in desiccators. And weigh it again (w2). 
% Loss on drying (LOD) = {(w1- w2) / w1} x 100 
2.2.2.5 Total ash  
 Crucible was heated to redness for 30 min and allowed to 
cool in a desiccators and weighed (w1). 3 gram of the 
powdered drug was carefully weighed in the above crucible. 
The gross weight of the crucible with the contents was noted 
(w2). Sample was evenly distributed and dried at 100-105ºC 
for 1 hour. Ignited to a constant mass .Allowing the crucible 
to cool in desiccators after ignition. Than crucible was cooled 
in desiccators and weighed. (w3). Total ash was calculated in 
% w/w by the following formula. 
Total ash in % w/w= {(w3-w1)/ (w2-w1)} X 100 
Where, w1-Weight of the empty crucible in grams 
             w2- Weight of the crucible + sample in grams 
            w3- Weight of the crucible + ash obtained in grams 
2.2.2.6 Bulk density 
Bulk density is defined as the mass of powder divided by 
bulk volume. 
Bulk density (Db) = mass of powder (M) / bulk volume 
(Vb) 
Bulk density was determined by measuring the amount of 
sample required to fill 3/4th volume of a 10ml. capacity 
graduated measuring cylinder via a funnel and measuring 
the volume occupied and weighed. (Lachman, L.et al. 1987, 
Aulton et al. 1988, Martin et al. 2005) 
2.2.2.7 Tapped density 
Tapped density is defined as the mass of powder divided by 
tapped volume. 
Tapped density (Dt) = mass of powder (M) /tapped 
volume (Vt) 
Tapped density was determined by tapping the graduated 
10ml. measuring cylinder 100 times from a height of about 
1.5 inch. (Lachman, L.et al. 1987,Aulton et al. 1999,  
Martin et al. 2005) 
2.2.2.7 % Compressibility  
% Compressibility was determined by the following formula  
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                      Tapped density    -   Bulk density 
% Compressibility =  ----------------------------------------- x 100 
                                             Tapped density 
2.2.2.8 Hausner’s ratio 
Hausner’s ratio was determined by the following formula. 
Tapped density / Bulk density 
2.2.2.9 pH  
pH was determined by pH meter. 
2.2.2.10 Particle size   
These studies were carried out by sieve analysis. Sieve no. 
60, 80 and 120 were used. Accurately weighed sample was 
placed (2 g) on topmost /coarsest sieve. Sieves were 
arranged in the ascending order from top. Agitated the nest 
of sieves for 5 minutes. Stopped the sieve shaker. Then 
carefully removed each sieve from the nest, without any loss 
of material. Reweighed each sieve and determined the 
weight of material on each one Determined the mass of 
material in the collecting pan. Reassembled the nest of 
sieves and agitated for another 5 min. This was done 
repeatedly for three times .After three times of agitation the 
end point criterion was achieved (when the change in mass 
of any of the test sieve is not more or less than 5% of the 
previous mass on that sieve). 
2.2.2.11 Extract excipients interaction study 
Powdered extracts excipients interaction study was 
performed by determination of total flavonoid in mixture of 
powder of Abutilon indicum, Zea mays, Tribulus terrestris , 
Phyllanthus niruri and excipients at initial, 15 and after 30 
days. 
2.2.3 Formulation of Tablets 
The dried powder extract and other ingredients were mixed 
uniformly and granules were prepared by wet granulation 
technique. The lubricated granules were compressed into 
tablets in an 8-station machine with 500 mg die cavity. 
Table 2 formula of Tablets 
Ingredient Quantity per tablet (mg) 
Abutilon indicum extract 150 
Zea mays extract 100 
Tribulus terrestris extract 50 
Phyllanthus niruri extract 50 
Lactose 90 
Talc 20 
Starch paste 3 % 
Starch dry 25 
 
2.3. Evaluation of Tablets (Indian pharmacopoeia 2007) 
Tablets were evaluated for their physical characteristics 
2.3.1. Organoleptic properties 
Size (thickness), shape, color, taste were determined. 
2.3.3. Weight Variation Test  
Weight variation test was done by weighing 20 tablets 
individually calculating the average weight and comparing 
the individual tablet to the average .The tablet given below 
shows the weight variation tolerance for uncoated tablets 
(Lachman ,L et al.,1991)  
 
 
Table 3   Weight variation tolerance for uncoated tablet 
Average weight of Tablet 
(mg) 
Maximum % deviation 
allowed  
130 mg or less  10 % 
130 mg to 324 mg  7.5 % 
More than 324 mg  5.0 % 
 
2.3.2. Tablet hardness  
The strength of tablet was expressed as tensile strength 
(Kg/cm2). The tablet crush load, in which the force required 
to break a tablet into halves by compression. It is measured 
using a tablet hardness tester (Monsanto hardness tester). 
The test was performed with five tablets. The mean value 
and the standard deviation were calculated (Lachman , L et 
al.,1991)  
2.3.4 Friability  
Friability test is performed to assess the effect of friction and 
shocks. Which may often cause tablet to chip ,cap or break 
.Roche friabilator was used for the purpose .This device 
subjects a number of tablets to the combined effect of 
abrasion and shock by utilizing a plastic chamber that 
revolves at 25 rpm dropping the tablet at distance of 6 
inches with each revolution.  Preweight sample of tablets 
were placed in the friabilator, which were then operated for 
100 revolutions. Tablets were dusted and reweigh. 
Compressed tablets should not loss more than 1% of their 
weight (Lachman, L et al., 1991). 
2.3.5 Disintegration Time  
One tablet was placed in each of six tubes of DT apparatus 
.Disintegration test was performed at 37 ±20C Disintegration 
time defined as time required to disintegrate and pass all 
fragments through the sieve (# 10) . (Lachman ,L et 
al.,1991). 
2.4 Antiurolithiatic activity of formulation (Mousa al 
Reza et al 2007, F. Atmani et al 2004, R. Vargas S. 1999) 
2.4.1 Experimental design 
Animal 4 groups and each group having 5 albino rats 
weighing 120-180 gm. were selected and housed under 
standard laboratory condition for a period of 14 days prior 
to the experiment. Experimental protocols were approved 
by our Institutional animal ethical committee, which follows 
guidelines of CPCSEA/ IAEC (Committee for the purpose of 
Control and Supervision of Experiments on 
Animals/Institutional Animal Ethics Committee), Reg. 
1839/PO/Ere/S/15/CPCSEA 
Model Ethylene glycol induced model 
Standard drug Cystone tablet 500 mg/kg body weight 
Method    0. 75% ethylene glycol induced kidney stone 
 2.4.2 Experimental group 
Four  groups contain  5 animals in  each group  were 
subjected to 0.75% ethylene glycol into drinking water for 
four weeks.  
GROUP I    : Control group received only drinking water. 
GROUP II: Model control group received drinking water +    
0.75% ethylene glycol                                                                   
GROUP III: received drinking water +0.75% ethylene glycol 
+ Formulated tablet 500 mg/kg 
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GROUP V:  received drinking water +0.75 % ethylene glycol 
+ Standard drug   500 mg/kg 
2.4.3 Statistical analysis 
Standard evaluation was done using one-way analysis of 
variance (ANOVA) Statistical significance was set at P< 
0.0001. Results are presented as mean ± standard errors (S 
.E.). (Mousa al reza Hadizadeh et al 2007) 
2.4.4 Parameters  
Total urinary volume 
 Animal were placed in separate metabolic cages 24 hours 
before the surgery. And total urinary volume was measured, 
by using measuring cylinder, and reported in ml (C.Barbas, 
A. Garcia 2002). 
Test for acidity 
Uric acid crystals were found to deposit most frequently in 
the concentrated acid urine. Thus the acidity of the urine 
was tested using pH meter (C.Barbas, A.Garcia 2002) 
Biochemical parameter of urine    
Urinary concentration of calcium, oxalate and Creatinine 
were measured (C.Barbas, A.Garcia 2002, Hodgkinson 
1970). 
3.1.1 Preformulation study of powders of extracts 
Preformulation study of powder  shows that % 
compressibility of were found  poor so they are unable to 
process as directly compressible formulation to give 
sufficient compressibility to the powder they should process 
through wet  granulation.( Table 13,14) . Angle of repose 
concluded that powders having poor flow so sufficient 
lubricant should be added, to improve flow of powder. 
3.1.2 Determination of total flavonoid content 
Total flavonoid content of ethanolic extract of Abutilon 
indicum  was found to be 0.765  (QE mg/100mg of extract), 
ethanolic extract of Zea mays was found to be 0.733  (QE 
mg/100mg of extract), ethanolic extract of Tribulus terrestris  
was found to be 0.744  (QE mg/100mg of extract) and 
ethanolic extract of Phyllanthus niruri was found to be 0.757 
(QE mg/100mg of extract). (Table 15)  
3.1.3 Drug - excipient interaction      
Drug -excipient interaction was performed by determination 
of total flavonoid content in mixture of powder extract of 
Abutilon indicum,Zea mays, Tribulus terrestris, Phyllanthus 
niruri and excipients at initial days and after 15, 30 days. 
Total flavonoid content were found 0.755 (QE mg/100mg of 
mixture) at initial day, 0.755 (QE mg/100mg of mixture) 
after 15 days, 0.755 (QE mg/100mg of mixture) after 30 
days. (Table 16) 
3.1.4  Evaluation of formulation (Tablets) 
The prepared tablets were subjected to post compression 
parameters i.e. thickness, weight variation, hardness, 
friability, Disintegration time, and total flavonoid content. 
Prepared tablet obey limit for all the physical parameter. 
(Table 17) 
3.1.5 Antiurolithiatic activity of formulation   
The changes in the urine parameters in the experiment 
animals during the study are presented (in Table 18, 19, 
20).The urine concentration of oxalate, calcium and 
Creatinine were increased significantly in animals 
administered with 0.75 percentage  ethylene glycol (group 
II). Four weeks treatment with formulated tablet 
significantly decreased urine concentration of oxalate (3.78 
± 0.07), calcium (2.82±0.13) and creatinine (4.51 ± 0.09) as 
compared to model control (oxalate – 11.29 ± 0.22, calcium – 
7.85± 0.19, Creatinine – 7.75 ± 0.17) (Table 20).Moreover 
the group treated with formulated tablets (150 mg Abutilon 
indicum + 100 mg Zea mays+ 50 mg Tribulus terrestris+ 50 
mg Phyllanthus niruri ) was found to be most significant 
from the entire group. The percentage reduction of all 
parameters of urine were found more in group III  (150 mg 
Abutilon indicum + 100 mg Zea mays+ 50 mg Tribulus 
terrestris+ 50 mg Phyllanthus niruri ) and in group IV 
(standard ). 
Urinary volume significantly decreased in the animals 
treated with the 0.75 % of ethylene glycol. Urinary volume 
were increased by 240 percentage in formulated tablet 246 
percentage standard drug with  compared to model control 
group.(Table 18)  Urinary pH significantly increased in the 
animals treated with the 0.75 % of ethylene glycol. Urinary 
pH were decreased by 25.95 percentage in formulated tablet 
and 26.96 percentage standard drug with compared to 
model control group.(Table 19)   From the above results it 
was noted that the formulated tablets were  found 
significant. 
4.1.10 Stability study of formulation 
The prepared tablets were subjected to post compression 
parameters i.e. thickness, weight variation, hardness, 
friability Disintegration time, and total flavonoid content 
after 3 month at room temperature and accelerated 
condition. Prepared tablets obey limit for all the physical 
parameter. The Prepared tablets were found stable after 3 
month. (Table 21)  
DISCUSSION  
Urorolithiasis is caused by several biochemical mechanisms. 
It is a generalized increase in the calcium content of the 
kidneys. The major causes include those associated with an 
increase in the urinary levels of calcium crystals 
precipitation. Kidney stones usually arise because of an 
imbalance between the kidney’s need to conserve fluid and 
the need to extrude waste products of low solubility. This 
imbalance often is precipitated by alternations in diet, fluid 
intake, climate and extent of physical activity.The majority of 
patients with calcium containing stones excretes excessive 
amounts of urinary calcium and often has urine that is 
supersaturated solution of calcium and oxalate salts. 
(Sarkisian M.R 2001) Animal model of kidney stone 
provide important tools for testing the pathogenesis of 
kidney stone and for studying the efficacy of potential 
therapies and their mechanism of action. In the recent years, 
important advances have been made in the diagnosis and 
treatment of kidney stones. Standard screening tests 
employed for the kidney stone study is the 0.75% ethylene 
glycol induced kidney stone method. It is an efficient method 
as kidney stone can be induces in animal in a very short 
duration of time by simultaneously testing the effect of test 
drug on the kidney stone in rats. 
In the present study of kidney stone, after the administration 
of ethanolic extract of Abutilon indicum,ethanolic extract of 
Zea mays, ethanolic extract of Tribulus terrestris and 
ethanolic extract of Phyllanthus niruri and their combination 
to the group of rats urine analysis shows that the occurrence 
of stone was decreased when compared to the kidney stone 
control group and combination (ethanolic extract of Abutilon 
indicum,ethanolic extract of Zea mays, ethanolic extract of 
Tribulus terrestris and ethanolic extract of Phyllanthus niruri) 
as effective as the standard group. 
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Under formulation development the components were 
examined for incompatibility, with dried extracts being as 
therapeutically active ingredient. The developed formulation 
was evaluated for various pharmaceutical parameters 
including stability studies at different environmental 
conditions. There was no significant physical change 
observed out in three month’s storage. Formulation showed 
marked antiurolithiatic activity on albino rats, it was 
concluded that the developed formulation show significant 
reduction in urine concentration oxalate, calcium and 
Creatinine.
 
Table 4  Preformulation study of powders 
S.No. Parameter Abutilon indicum        Zea mays Tribulus terrestris Phyllanthus niruri 
1 Description Light Brown Powder 
with characteristic 
odour 






Dark green Powder 
with characteristic 
odour 
2 Solubility   
  Alcohol Soluble Soluble Soluble Soluble 
  Water (pH 7 ) Slightly soluble Slightly soluble Slightly soluble Slightly soluble 
  0.1 N HCl solution Soluble Soluble Soluble Soluble 
  Ethyl acetate Insoluble Insoluble Soluble Insoluble 
  Hexane Insoluble Insoluble Insoluble Insoluble 
 
Table 5  Preformulation study of powders 
S.No Parameter Abutilon indicum Zea mays Tribulus terrestris Phyllanthus niruri 
1 Angle of repose 32 30 31 31 
2 Loss on drying 12.4% 10.9% 9.8% 11.2% 
3 Ash value 3.98% 3.85% 4.1% 3.98% 
4 Bulk density 0.66 g/ml 0.69 g/ml 0.67g/ml 0.65g/ml 
5 Tapped density 0.88g/ml 0.94g/ml 0.91g/ml 0.87g/ml 
6 % compressibility 17.92% 18.49% 17.88% 18.22% 
7 Hausner ratio 1.19 1.21 1.17 1.23 
8 pH  6.3 6.5 6.4 6.5 
9 Particle size 50-150 µ 50-150 µ 50-150 µ 50-150 µ 
 
Table 6 Determination of total flavonoid content 
S.No. Extract Total flavonoid Content (QE mg/100mg of extract) 
1 Ethanolic extract of Abutilon indicum  0.765 
2 Ethanolic extract of Zea mays 0.733 
3 Ethanolic extract of Tribulus terrestris 0.744 
4 Ethanolic extract of Phyllanthus niruri 0.757 
 
Table 7 Drug - excipient interaction 
S.No. Day Determination of total flavonoid 
content (QE      mg/100mg) 
1 initial 0.755 
2 After 15 days 0.755 
3 After 30 days 0.755 
QE- Quercetin equivalents 
Powder of Abutilon indicum extract + Powder of Zea mays 
extract+ Powder of Tribulus terrestris + Powder of  
Phyllanthus niruri + Excipient 
Table 8 Evaluation of Tablet 
S.No. Evaluation parameter Observation 
1 Size (Thickness) 4.7± 0.15 mm 
2 Shape Round 
3 Color Light brown 
4 Taste Characteristic 
5 Weight variation Upper limit 1.3% 
Lower limit 1.7% 
6 Hardness 4.35 kg/cm2 
7 % Friability 0.8% 
8 Disintegration time 10 min. 
 
 
Antiurolithiatic activity of Formulation 
Table 9 Total urinary volume 
S.No. Groups Total urinary 
volume (ml) 
Mean± SE 
1. Normal control 2.44 ±0.14 
2. Model control 1.57 ± 0.10 
3 Formulated tablet  5.35 ± 0.17 *** 
4 Standard drug   500  mg/kg 5.44 ± 0.15 *** 
 
P<0.001, the treated groups are compared with groups I and 
II. Values are expressed in Mean±SEM, Statistics: one way 
ANOVA followed by Dunnet’s test, *** highly significant, ** 
significant and * less significant 
Table 10 Determination of urinary pH 
S.No. Groups pH of urine 
1. Normal  control 7.25 ± 0.17 
2. Model control 9.94 ± 0.23 
4 Formulated tablet  7.36 ± 0.15** 
5 Standard drug   500  mg/kg 7.26 ± 0.19*** 
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P<0.001, the treated groups are compared with groups I and 
II. Values are expressed in Mean±SEM, Statistics: one way 
ANOVA followed by Dunnet’s test, *** highly significant, ** 
significant and * less significant 
 
Table 11 Biochemical parameter of Urine 
S. no. Group Urine parameter (mg/ dl) 
  Oxalate Calcium Creatinine 
1 Normal control 3.65 ± 0.08 2.75±0.10 4.35 ± 0.16 
2 Model control 11.29 ± 0.22 7.85± 0.19 7.75 ± 0.17 
3 Formulation(500 mg/kg) 3.78 ± 0.07*** 2.82±0.13** 4.51 ± 0.09** 
4 Standard (500mg/kg) 3.81 ± 0.06 *** 2.77±0.09*** 4.45 ± 0.12*** 
 
Table 12 Stability study 
Parameters Formulation at Different Time Interval 
0th Day After 3 month 
Accelerated 
Condition 






Weight variation  
(Avg. Weight-502.7 mg) 
Disintegration Time (min)   







5 Limit  
10 
 0.755 
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